Medications
How the drug abemaciclib treats breast cancer
The anti-cancer drug abemaciclib (also known as Vernezio) has been added to the Australian Pharmaceutical Benefits Scheme (PBS) to treat certain types of breast cancer.
19 hours ago
0
0
Sorted by liverank
Oncology & Cancer
Massive study identifies new biomarkers for renal cancer subtypes, improving diagnosis and—eventually—treatment
A new study led by University of Michigan Health Rogel Cancer Center researchers identifies novel biomarkers in renal cell carcinomas. The researchers' integrative analysis of comprehensive proteogenomic datasets from both ...
May 6, 2024
0
7
Oncology & Cancer
Study uncovers at least one cause of roadblocks to cancer immunotherapy
T cells—the body's foot soldiers against invaders, ranging from everyday infections to cancers—are integral to many successful immunotherapies. However, a frustrating factor is that immunotherapies do not always work.
May 6, 2024
0
111
Medications
Drug shows promise for starving out cancer cells
Starving out tumor cells may be a promising therapy for treatment-resistant lung cancer, according to a new study published in Science Advances.
May 6, 2024
0
26
Oncology & Cancer
Study provides a blueprint of tumor-infiltrating B cells with therapeutic implications
In a study published in Science on May 3, researchers unveiled two responding patterns of tumor-infiltrating B cells with therapeutic implications.
May 6, 2024
0
29
Oncology & Cancer
Scientists track earliest cancer-triggering physical changes in cells
By the time cancer is diagnosed, a lot has already happened behind the scenes. Although cancers are classed into early and late stages for clinical purposes, even an "early" stage tumor is the result of many previous, undetectable ...
May 6, 2024
0
24
Oncology & Cancer
Knocking out deadly brain cancer with a dual therapy
Glioblastoma is an often fatal form of brain cancer, with only 5% of patients surviving beyond five years. The cancer is difficult to treat and almost always becomes resistant to treatment. As a result, recurrence of glioblastoma ...
May 6, 2024
0
1
Oncology & Cancer
New research examines past and guides future efforts to reduce cancer disparities
Investigators at Dana-Farber Cancer Institute have examined the historical evolution of Community Outreach and Engagement initiatives at both the National Cancer Institute (NCI) and National Cancer Institute-Designated Cancer ...
May 6, 2024
0
0
Oncology & Cancer
Researchers generate direct measurement of interaction between immune cells and cancer cells from a patient's biopsy
Researchers at Bar-Ilan University have unveiled a technology that promises to improve cancer treatment decisions based on a patient's biopsy. The pioneering biological research and development measures changes in immune ...
May 6, 2024
0
2
Oncology & Cancer
Exploring oncogenic driver molecular alterations in Hispanic/Latin American cancer patients
In an editorial, published in Oncoscience, researcher Rafael Parra-Medina from Fundación Universitaria de Ciencias de la Salud and Instituto Nacional de Cancerología discusses Latin America's (LA) population—a heterogeneous ...
May 6, 2024
0
0
